Donate Connect
SEARCH

FOP News

Ipsen Announces Re-Examination of Palovarotene Confirms Negative Opinion Given in January 2023

Posted by · May 26, 2023 2:03 PM
Read more Share

U.S. FDA Advisory Committee Meeting on Palovarotene Rescheduled for June 28, 2023

Posted by · May 25, 2023 4:48 PM
Read more Share

IPSEN Receives New PDUFA Date from the U.S. FDA

Posted by · March 16, 2023 11:04 AM
Read more Share

Ipsen Receives EMA CHMP Opinion for Palovarotene

Posted by · January 27, 2023 8:12 AM
Read more Share

"I Knew if There Was a Mutation, Meiqi Would Find It!”

Posted by · January 24, 2023 3:33 PM
Read more Share

IPSEN Publishes Results of Phase III MOVE Clinical Trial

Posted by · January 18, 2023 11:06 AM
Read more Share

LUMINA-1 Phase II Clinical Trial Results Published in medRxiv

Posted by · January 13, 2023 7:20 PM
Read more Share

Ipsen Receives Complete Response Letter from U.S. FDA

Posted by · December 23, 2022 6:55 PM
Read more Share

Tell the FDA What It's Like to Live With FOP

Posted by · December 13, 2022 1:17 PM
Read more Share

Regeneron OPTIMA Phase III Trial Now Recruiting

Posted by · December 09, 2022 6:50 PM
Read more Share

Learn More

Is it FOP? Just Diagnosed Registry

Make a Difference

Donate Connect Fundraise
Sign in with Facebook, Twitter or email.
Site by Mosaic • Created with NationBuilder
Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter